Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • English
    • Deutsch
    • Français
    • Italiano
    • Português
    • Español
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • UpDate Dementia Research

Diagnosis and therapy of the momentous disease of old age

    • Congress Reports
    • Geriatrics
    • Neurology
    • RX
  • 3 minute read

Current demographic trends are leading to a growing number of elderly people and thus to an increase in patients suffering from age-related diseases such as dementia. Addressing this health challenge requires a precise diagnostic process as well as effective treatment strategies.

Current demographic trends are bringing with them a growing number of older people. Accordingly, age-related diseases are on the rise. Dementia is estimated to affect 131.5 million patients by 2050. Dementia is an umbrella term for brain disorders of various causes. Patients increasingly suffer from a loss of memory, orientation, communication and independent living skills (overview 1).

 

 

Phased progression

Scientists believe that the disease is asymptomatic for as long as 30 years before the first signs are seen. The first indications of changes can already be found after puberty, although the amyloid plaques do not become visible until much later. Different biomarkers in the cerebrospinal fluid can also be detected as early as 20 years before the onset of the disease. These include, for example, beta-amyloid peptides and tau protein. If these accumulate over time and a critical threshold is exceeded, the pre-dementia phase begins. In this first, occasional cognitive failures become noticeable. The ability to remember and concentration decrease.

Then, within the next four years, there is a significant decrease in brain mass in the hippocampus. Language and speech comprehension suffer and everyday life also becomes more difficult. While in the beginning it seems to be more the short-term memory that is affected, now the long-term memory is also fading more and more. Experiences of the past years are forgotten, whereas memories from childhood are suddenly experienced as having just happened. The patient’s personality also changes. Distrust, irritability, nervousness and aggressive outbursts are an expression of the progressive disorientation.

In the late stage, physical deterioration also begins. Patients often suffer from muscle spasms and stiff joints. In the end, they become bedridden nursing cases. Language dries up and new ways of communication have to be found.

Dementia equals Alzheimer’s?

In addition to the current 148,000 dementia patients in Switzerland, an estimated 28,000 new patients are diagnosed each year. Alzheimer’s disease is the most common form of dementia, accounting for over half of all diagnosed cases, followed by vascular dementia (20%). Particularly in older age, however, mixed forms are also frequently present.

Accordingly, precise diagnostics are important in order to be able to initiate the appropriate individually effective therapies. Neuropsychological testing is very comprehensive and covers a total of six domains (Fig. 1) . As a rule, paper-pencil tests are performed, which incl. Anamnesis take about 2.5 hours. Increasingly, however, tablet-based self-tests are being used. A medical examination, an MRI and, if necessary, a cerebrospinal fluid analysis complete the diagnostic process. Another step in the right direction can be meaningful biomarkers that can be detected in the blood. Intensive research is currently being conducted into this.

 

 

Multimodal therapy regime

Effective diagnosis is also important in view of the fact that dementia cannot be cured, but its course can be positively influenced in its early stages. Multimodal therapy consisting of pharmacological intervention, memory training, and behavioral and sociological therapy is indicated. For pharmacotherapy, antidementia drugs are primarily used. In mild to moderate dementia, acetylcholinesterase inhibitors in particular have been shown to be effective. Both donepezil and rivastigmine and galantamine resulted in improvements in cognition, daily living skills, and behavior. Cholinesterase inhibitors block the enzyme responsible for breaking down acetylcholine. The concentration of the messenger substance increases accordingly.

In severe AD, donepezil or the NMDA receptor modulator memantine are used. Glutamate antagonists block glutamate receptor sites at synapses, inhibiting excitation transmission at neurons regulated by glutamate.

Future treatment options

New therapeutic approaches are being investigated, particularly with regard to β-amyloid accumulation. The monoclonal antibody binds to soluble and insoluble beta-amyloid in the brain and leads to a significant reduction of the neurotoxic peptide. New analyses of a Phase III study are expected to prove that the hopes placed in the new substance are justified. After initially a lack of prospect for a significant effect led to the study’s discontinuation, new information has now been published. At high doses, the new Alzheimer’s drug may well be able to reduce cognitive decline in early-stage Alzheimer’s patients. Patients treated with high-dose aducanumab (10 mg/kg body weight) showed a significant reduction in clinical worsening from baseline CDR-SB scores at 78 weeks (23% vs. placebo, p=0.01).

Source: Basel Dementia Forum
 

Further reading:

  • www.beobachter.ch/gesundheit/krankheit/demenz (last accessed on 14.01.2020)
  • www.bag.admin.ch/bag/de/home/krankheiten/krankheiten-im-ueberblick/demenz.html (last accessed on 14.01.2020)
  • https://alzheimer.ch/de/angehoerige/diagnose/magazin-detail/50/alzheimer-ist-die-haeufigste-form-von-demenz/ (last accessed on 14.01.2020)
  • www.nature.com/articles/s41582-019-0295-9 (last accessed on 14.01.2020)
  • www.dasgehirn.info/krankheiten/morbus-alzheimer/schleichend-zum-vergessen?gclid=EAIaIQobChMI0Ob-ruqH5wIVFODtCh2-Ew2uEAAYAiAAEgIMCPD_BwE (last accessed 16.01.2020)

 

InFo NEUROLOGY & PSYCHIATRY 2020, 18(1): 36-37 (published 1/23/20, ahead of print).

Publikation
  • InFo NEUROLOGIE & PSYCHIATRIE
Related Topics
  • Alzheimer
  • Dementia
  • multimodal therapy
Previous Article
  • Acute coronary syndrome

Utility of fSENC MRI in the acute setting.

  • Cardiology
  • Congress Reports
  • RX
View Post
Next Article
  • Psoriasis and cardiovascular comorbidities.

Complex interaction structure: Implications for therapy

  • Cardiology
  • Congress Reports
  • Dermatology and venereology
  • RX
  • Studies
View Post
You May Also Like
View Post
  • 5 min
  • Asthma in adults

When do pneumology specialists come into play?

    • RX
View Post
  • 10 min
  • Cutaneous lupus erythematosus

From diagnostic workup to successful treatment

    • Congress Reports
    • Dermatology and venereology
    • RX
    • Studies
View Post
  • 4 min
  • Guideline update

Dietary recommendations for Crohn’s disease and colitis

    • Education
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Nutrition
    • RX
    • Studies
View Post
  • 4 min
  • Circadian rhythm during Ramadan

Disturbed sleep patterns lead to metabolic stress

    • Education
    • Endocrinology and Diabetology
    • General Internal Medicine
    • Nutrition
    • RX
    • Studies
View Post
  • 6 min
  • Case Report

Breast cancer metastases in the bladder

    • Cases
    • Education
    • Gynecology
    • Oncology
    • RX
    • Urology
View Post
  • 11 min
  • Findings from the ALS Symposium 2024 in Montreal

Current and future approaches in the treatment of amyotrophic lateral sclerosis (ALS)

    • Congress Reports
    • Interviews
    • Neurology
    • RX
    • Studies
View Post
  • 8 min
  • Efficacy, mechanism of action and clinical effects

Garlic and high blood pressure

    • Cardiology
    • Education
    • General Internal Medicine
    • Pharmaceutical medicine
    • Phytotherapy
    • RX
    • Studies
View Post
  • 7 min
  • Moderate to severe chronic hand eczema

Delgocitinib cream – first topical pan-JAK inhibitor approved in Switzerland

    • Allergology and clinical immunology
    • Dermatology and venereology
    • Education
    • Infectiology
    • Market & Medicine
    • Pharmacology and toxicology
    • RX
Top Partner Content
  • Forum Gastroenterology

    Zum Thema
  • Herpes zoster

    Zum Thema
  • Dermatology News

    Zum Thema
Top CME content
  • 1
    Patience, knowledge and persistence in therapy
  • 2
    Sarcopenia and malnutrition in the context of pneumological rehabilitation
  • 3
    Medical and psychosocial perspectives
  • 4
    New nomenclature for non-alcoholic fatty liver disease
  • 5
    Examinations and considerations before therapy

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.